Novavax (NVAX) Interest Coverage Ratio (QoQ) (2010 - 2026)
Novavax (NVAX) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -279.76% |
| Dec 31, 2025 | 105.86% |
| Sep 30, 2025 | -227.05% |
| Jun 30, 2025 | -79.67% |
| Mar 31, 2025 | 3,891.46% |
| Dec 31, 2024 | 92.49% |
| Sep 30, 2024 | -181.41% |
| Jun 30, 2024 | 210.30% |
| Mar 31, 2024 | -6.19% |
| Dec 31, 2023 | 24.50% |
| Sep 30, 2023 | -347.54% |
| Jun 30, 2023 | 137.27% |
| Mar 31, 2023 | -3,315.74% |
| Dec 31, 2022 | 95.43% |
| Sep 30, 2022 | 60.62% |
| Jun 30, 2022 | -346.31% |
| Mar 31, 2022 | 816.79% |
| Dec 31, 2021 | 92.60% |
| Sep 30, 2021 | -2.29% |
| Jun 30, 2021 | -109.14% |